Works matching DE "PEMETREXED"
Results: 766
Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13785-x
- By:
- Publication type:
- Article
Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial–Mesenchymal Transition (EMT) in Lung Cancer Subclones.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1766, doi. 10.3390/ijms26041766
- By:
- Publication type:
- Article
Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 7, p. 2722, doi. 10.1002/ange.201914453
- By:
- Publication type:
- Article
Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy.
- Published in:
- International Archives of Occupational & Environmental Health, 2022, v. 95, n. 2, p. 399, doi. 10.1007/s00420-021-01738-3
- By:
- Publication type:
- Article
A Comparative Study Between Pemetrexed and Taxanes as First Line Treatment of Metastatic Lung Adenocarcinoma.
- Published in:
- Diyala Journal of Medicine, 2024, v. 26, n. 2, p. 141, doi. 10.26505/DJM.26027690709
- By:
- Publication type:
- Article
Combinatorial treatment using bevacizumab/pemetrexed loaded core-shell silica nanoparticles for non-small cell lung cancer.
- Published in:
- Science & Technology of Advanced Materials, 2023, v. 24, n. 1, p. 1, doi. 10.1080/14686996.2023.2274819
- By:
- Publication type:
- Article
GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15302
- By:
- Publication type:
- Article
Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.14538
- By:
- Publication type:
- Article
Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.12081
- By:
- Publication type:
- Article
Updates from ASCO 2014 and ESMO 2014.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 1, p. 23
- Publication type:
- Article
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63172-y
- By:
- Publication type:
- Article
Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 12, p. 1787, doi. 10.3390/biom12121787
- By:
- Publication type:
- Article
The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1396, doi. 10.3390/biom10101396
- By:
- Publication type:
- Article
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 8, p. 1113, doi. 10.3390/biom10081113
- By:
- Publication type:
- Article
Antiangiogeneic Strategies in Mesothelioma.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00126
- By:
- Publication type:
- Article
A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00838
- By:
- Publication type:
- Article
Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00538
- By:
- Publication type:
- Article
LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 75, doi. 10.2147/LCTT.S460147
- By:
- Publication type:
- Article
Co-Occurring EGFR S645C and EGFR L858R in a Patient with Lung Adenocarcinoma Induced Primary Resistance to Osimertinib.
- Published in:
- Lung Cancer: Targets & Therapy, 2023, v. 14, p. 79, doi. 10.2147/LCTT.S431252
- By:
- Publication type:
- Article
Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer.
- Published in:
- Lung Cancer: Targets & Therapy, 2015, v. 6, p. 13, doi. 10.2147/LCTT.S73268
- By:
- Publication type:
- Article
Genomic Characterization of Radiation-Induced Intracranial Undifferentiated Pleomorphic Sarcoma.
- Published in:
- Case Reports in Genetics, 2021, p. 1, doi. 10.1155/2021/5586072
- By:
- Publication type:
- Article
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1641, doi. 10.1007/s40273-023-01305-3
- By:
- Publication type:
- Article
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 8, p. 945, doi. 10.1007/s40273-023-01279-2
- By:
- Publication type:
- Article
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 4, p. 353, doi. 10.1007/s40273-023-01247-w
- By:
- Publication type:
- Article
Survivin degradation by bergenin overcomes pemetrexed resistance.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1837, doi. 10.1007/s13402-023-00850-5
- By:
- Publication type:
- Article
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Journal of Lipids, 2024, p. 1, doi. 10.1155/2024/6730504
- By:
- Publication type:
- Article
High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019.
- Published in:
- Clinical Epidemiology, 2021, v. 13, p. 1085, doi. 10.2147/CLEP.S332776
- By:
- Publication type:
- Article
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation.
- Published in:
- Clinical Epidemiology, 2021, v. 13, p. 871, doi. 10.2147/CLEP.S326470
- By:
- Publication type:
- Article
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02284-7
- By:
- Publication type:
- Article
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02118-y
- By:
- Publication type:
- Article
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01985-9
- By:
- Publication type:
- Article
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01938-2
- By:
- Publication type:
- Article
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 4, p. 461, doi. 10.1111/pcmr.13042
- By:
- Publication type:
- Article
Effect of Fractionated Low-LET Radiation Exposure on Cervical Cancer Stem Cells under Experimental and Clinical Conditions.
- Published in:
- Biology Bulletin, 2020, v. 47, n. 11, p. 1471, doi. 10.1134/S1062359020110096
- By:
- Publication type:
- Article
Chemoradiotherapy with high‐dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2021, v. 65, n. 6, p. 796, doi. 10.1111/1754-9485.13292
- By:
- Publication type:
- Article
Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Current treatments and trials in malignant pleural mesothelioma.
- Published in:
- Clinical Respiratory Journal, 2018, v. 12, n. 7, p. 2161, doi. 10.1111/crj.12938
- By:
- Publication type:
- Article
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01876-1
- By:
- Publication type:
- Article
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01842-x
- By:
- Publication type:
- Article
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01662-5
- By:
- Publication type:
- Article
Colitis induced by PD-1 inhibitor combined with platinum-containing dual drug chemotherapy in Lewis mice and its mechanism.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 4, p. 939, doi. 10.4103/jcrt.jcrt_2078_22
- By:
- Publication type:
- Article
A combination of anti‑PD‑1 therapy and apatinib successfully treated a patient with EGFR mutation‑negative advanced lung adenocarcinoma: A case report.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 1, p. 141, doi. 10.4103/jcrt.jcrt_1710_21
- By:
- Publication type:
- Article
A combination of anti-PD-1 therapy and apatinib successfully treated a patient with EGFR mutation-negative advanced lung adenocarcinoma: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 380, doi. 10.1111/ajco.12513
- By:
- Publication type:
- Article
Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 1, p. 85, doi. 10.1111/ajco.12306
- By:
- Publication type:
- Article
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 4, p. 331, doi. 10.1111/ajco.12060
- By:
- Publication type:
- Article
Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer.
- Published in:
- Cell Biochemistry & Biophysics, 2024, v. 82, n. 2, p. 1421, doi. 10.1007/s12013-024-01296-8
- By:
- Publication type:
- Article
Predominance of MGMT promoter methylation among Pakistani glioblastoma patients.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09363-2
- By:
- Publication type:
- Article
MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6).
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09207-z
- By:
- Publication type:
- Article